Can Heavy Metal Exposure Contribute to Low Estrogen and Early Menopause?

Devin Wilson, ND • October 27, 2026

Share this article

Research suggests that exposure to certain heavy metals may disrupt hormone levels in women and potentially contribute to earlier natural menopause.

Heavy Metals and Hormone Imbalance

A 2024 analysis from the Study of Women’s Health Across the Nation (SWAN) Multi-Pollutant Study investigated the relationship between urinary heavy metal concentrations and reproductive hormone levels in more than 1,000 midlife women. Researchers assessed exposure to metals including arsenic, cadmium, lead, and mercury, alongside hormone markers such as estradiol (E2), follicle-stimulating hormone (FSH), and sex hormone-binding globulin (SHBG).

The study found that higher exposure to certain metals, particularly mercury, lead, and cadmium, was associated with lower estradiol and higher FSH and SHBG levels . These hormonal changes may reflect disruption of normal reproductive hormone regulation.

Estradiol is a primary form of estrogen, while FSH typically rises as ovarian function declines during the menopausal transition. SHBG binds to sex hormones and influences how much is available to tissues.

The authors concluded:

“Results from this prospective cohort study demonstrate that environmental heavy metal exposures, including cadmium, mercury, and lead, may disturb circulating levels of E2, FSH, and SHBG in midlife women.”

Heavy Metals and Earlier Menopause

A 2021 study examined whether exposure to heavy metals was associated with the timing of natural menopause. Researchers measured urinary concentrations of metals, including arsenic, barium, cadmium, lead, and mercury, in premenopausal women and followed them for an average of four years to assess menopausal status.

The findings suggested that higher urinary arsenic and lead levels were associated with an increased risk of earlier menopause . Specifically, urinary arsenic was associated with a 32% higher risk, while urinary lead was associated with a 36% higher risk.

The authors concluded:

“This study suggests that arsenic, lead, and metal mixtures are associated with earlier natural menopause, a risk factor for adverse health outcomes in later life.”

What Do These Findings Mean?

Together, these studies suggest that environmental exposure to certain heavy metals may be associated with changes in reproductive hormone levels and the timing of menopause. However, association does not establish causation . These findings do not prove that heavy metals directly cause low estrogen or early menopause, and additional research is needed to clarify the underlying mechanisms and clinical significance.

Women experiencing irregular periods, symptoms of low estrogen, or signs of early menopause should discuss appropriate hormone testing and evaluation with a qualified healthcare professional. When exposure is suspected, testing and follow-up should be guided by the specific metal, potential exposure source, and clinical circumstances.

Learn More at Valley Integrative Health

Devin Wilson, ND, is a licensed naturopathic doctor and owner of Valley Integrative Health, LLC, in Ashland, Oregon. With over a decade of clinical experience, Dr. Wilson integrates naturopathic and modern medicine using a patient-centered, holistic approach. He has advanced training in chelation therapy through the American College for Advancement in Medicine (ACAM) and is a Certified Chelation Therapy provider. Dr. Wilson also has advanced training in anti-aging medicine and bioidentical hormone therapy through the American Academy of Anti-Aging Medicine (A4M).

Sources

  1. Study of Women’s Health Across the Nation (SWAN) Multi-Pollutant Study: Heavy metals and reproductive hormone levels
  2. Environmental metal exposure and earlier natural menopause

This article is for educational purposes only and is not a substitute for individualized medical advice, diagnosis, or treatment.

Recent Posts

By Devin Wilson, ND • October 28, 2026
Emerging research suggests even low levels of lead exposure may increase cardiovascular risk. Learn how lead affects the heart, common sources, testing, and nutritional support.
By Devin Wilson, ND • October 28, 2026
Can mold exposure contribute to persistent fatigue? Explore what clinical studies reveal about indoor dampness, mycotoxins, and ME/CFS.
By Devin Wilson, ND • October 28, 2026
An overview of hormones, aging, hormone therapy terminology, bioidentical hormones, testing, and what to do next.
By Devin Wilson, ND • October 28, 2026
Does hormone therapy cause cancer? A nuanced look at the WHI, estrogen versus progestogen, and how to weigh risks and benefits individually.
By Devin Wilson, ND • October 28, 2026
A look at what decades of research show about menopausal hormone therapy, brain, heart, bone and sexual health, and why formulation and timing matter.
By Devin Wilson, ND • October 28, 2026
Lifestyle changes and targeted supplements that may support hormone health, what the research shows, and where they fall short of hormone replacement.
By Devin Wilson, ND • October 28, 2026
Symptoms of low testosterone, associated health risks, what clinical trials show about replacement, and when treatment may be appropriate.
By Devin Wilson, ND • October 28, 2026
How estrogen and testosterone relate to brain, bone and cardiovascular health, and how to reassess the risks and benefits of hormone therapy.
By Devin Wilson, ND • October 27, 2026
Learn what chelation therapy is, how it is administered, its safety, its established uses for heavy metal poisoning, and what research says about cardiovascular and other conditions.
By Devin Wilson, ND • October 27, 2026
Explore what research says about lead, mercury, cadmium and arsenic and their possible links to depression and anxiety, and when testing may be worth discussing.
Show More